Getting a Leg Up on Cardiovascular Disease: Secondary Prevention in Artherothrombosis Sponsored by BMS Pharmaceuticals and sanofi aventis Pharmaceuticals 2 Category 1-B AOA Credit
The goal of this online CME is to educate primary care providers about the risks posed by atherothrombosis and the evidence-based measures that can be taken to improve the recognition and treatment of patients with PAD and post ACS/stroke so as to reduce future MI and stroke.
Specifically it will address:
the common underpinning of atherothrombosis in the cerebrovascular, coronary, and peripheral artery beds;
the risk factors and epidemiology of cardiovascular events in PAD, post-ACS, and post-stroke patients;
therapeutic approaches to reducing the risk factors for atherothrombosis;
recent treatment guidelines for secondary prevention in ACS, stroke, and PAD patients;
the gap between evidence-based therapy and practice;
the impact of increased evidence-based care out patient outcomes.
Unraveling the Mystery of Glycemic Control: Spotlight on Insulin Analogs Sponsored by Novo Nordisk, Inc.
2 Category 1-B credit anticipated Link to online presentation
